Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study) | Zendy

Eugènia Negredo | Zendy; Peré Domingo | Zendy; Núria PérezÁlvarez | Zendy; Mar Gutiérrez | Zendy; Gràcia Mateo | Zendy; Jordi Puig | Zendy; Roser Escrig | Zendy; Patricia Echeverría | Zendy; Anna Bonjoch | Zendy; Bonaventura Clotet | Zendy

Open Access

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Author(s) -

Eugènia Negredo,

Peré Domingo,

Núria PérezÁlvarez,

Mar Gutiérrez,

Gràcia Mateo,

Jordi Puig,

Roser Escrig,

Patricia Echeverría,

Anna Bonjoch,

Bonaventura Clotet

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku300

Subject(s) - abacavir , medicine , bone mineral , discontinuation , osteopenia , tenofovir , osteoporosis , randomized controlled trial , human immunodeficiency virus (hiv) , surgery , viral load , antiretroviral therapy , virology

Tenofovir has been associated with a decrease in bone mineral density (BMD). However, data on changes in BMD after discontinuing tenofovir are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research